Xiaorong Mao

Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial

Jian Zhou, Li Bai, Jia Luo et al. · The Lancet Oncology · 2025 · 41 citations

Medicine, Oncology, Pharmacotherapy +10

Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro

Liting Zhang, Xuebin Peng, Xue-Qin Fang et al. · International Journal of Molecular Medicine · 2018 · 29 citations · Full text

Life Sciences, Biotechnology, Cell Biology +15

Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis

Aiping Tian, Ke Pu, Boxuan Li et al. · Hepatology Research · 2019 · 26 citations · Full text

Medicine, Molecular Biology, Oncology +17

Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study

Shuai Wang, Yifei Huang, Weiling Hu et al. · The Lancet Regional Health - Western Pacific · 2020 · 26 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Development and validation of a radiomics signature as a non‐invasive complementary predictor of gastroesophageal varices and high‐risk varices in compensated advanced chronic liver disease: A multicenter study

Yifei Huang, Fangze Huang, Li Yang et al. · Journal of Gastroenterology and Hepatology · 2020 · 24 citations · Full text

Medicine, Radiology, Diagnostic Imaging +16